Literature DB >> 4332626

Hypertension of renal origin: evidence for two different mechanisms.

H R Brunner, J D Kirshman, J E Sealey, J H Laragh.   

Abstract

Antibody to angiotensin 11, or a specific peptide competitive inhibitor of angiolensin II, was used to investigate the role of the renin-angiotensin system in two types of renal hypertension in rats. The data indicate that angiotensin II is in fact critically involved in the pathogenesis of the form of renal hypertension in which one renal artery is clamped and the contralateral kidney is left in place, but that it probably plays no significant role in the maintenance of experimental renal hypertension in which the opposite kidney has been removed.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4332626     DOI: 10.1126/science.174.4016.1344

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  33 in total

1.  Experimental renal hypertension in rats.

Authors:  E Tarján; A Fekete
Journal:  Int Urol Nephrol       Date:  1975       Impact factor: 2.370

2.  First International Symposium on Cilazapril Preclinical and Clinical Pharmacology. Lausanne, switzerland, May 5-7, 1988. Proceedings.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

Review 3.  ACE inhibitors in renovascular hypertension.

Authors:  S C Textor
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

Review 4.  Success and failure of vaccines against renin-angiotensin system components.

Authors:  Morris J Brown
Journal:  Nat Rev Cardiol       Date:  2009-08-25       Impact factor: 32.419

5.  Morphometric analysis of hypertension-induced hypertrophy of rat thoracic aorta.

Authors:  J Wiener; A V Loud; F Giacomelli; P Anversa
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

6.  Current opinions in renovascular hypertension.

Authors:  Ankit N Mehta; Andrew Fenves
Journal:  Proc (Bayl Univ Med Cent)       Date:  2010-07

7.  Regional distribution of vascular resistance in two models of experimental renovascular hypertension.

Authors:  H Flohr; W Breull; H W Dahners; D Redel; H Conradi; K Stoepel
Journal:  Pflugers Arch       Date:  1976-03-30       Impact factor: 3.657

8.  Elevated blood pressure aggravates intracerebral hemorrhage-induced brain injury.

Authors:  Yan-Hua Sang; Huan-Xing Su; Wu-Tian Wu; Kwok-Fai So; Raymond Tak-Fai Cheung
Journal:  J Neurotrauma       Date:  2011-10-11       Impact factor: 5.269

Review 9.  Diagnostic criteria for renovascular disease: where are we now?

Authors:  Sandra M S Herrmann; Stephen C Textor
Journal:  Nephrol Dial Transplant       Date:  2012-07       Impact factor: 5.992

Review 10.  Malignant or accelerated hypertension.

Authors:  N D Vaziri
Journal:  West J Med       Date:  1984-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.